WH Jr Miller

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Josephia R. Muindi, SR Frankel, WH Jr Miller et al. · Blood · 1992 · 411 citations · Full text

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Josephia R. Muindi, SR Frankel, WH Jr Miller et al. · Blood · 1992 · 318 citations · Full text

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid

Linda T. Vahdat, P. Maslak, WH Jr Miller et al. · Blood · 1994 · 302 citations · Full text

Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA

WH Jr Miller, Kristi Levine, A DeBlasio et al. · Blood · 1993 · 216 citations · Full text

Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines

Andreas Rosenauer, JV Raelson, Clara Nervi et al. · Blood · 1996 · 80 citations